GYRE — GYRE THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 63 SEC-registered investment managers reported holding GYRE (GYRE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $61.56M across 9.35M shares. That is +14.6% by share count (+487.94K shares) versus the previous quarter, while reported value moved +8.4%. Ownership is concentrated: the five largest holders account for 76.1% of reported value and the top ten for 89.5%.
Compared with the prior quarter, 16 opened new positions, 30 added to existing stakes, 9 trimmed, 9 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of GYRE THERAPEUTICS INC (GYRE) include HSG Holding Ltd, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock Inc, ranked by reported 13F value among the 106 institutional holders on this page.
GYRE is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 40 | 8.34M | $61.14M | +17.3% |
| Q2 2026 | 63 | 9.35M | $61.56M | +14.6% |
| Q1 2026 | 56 | 3.57M | $24.90M | +3.0% |
| Q4 2025 | 44 | 3.52M | $24.88M | +10.9% |
| Q3 2025 | 48 | 3.27M | $24.39M | -9.5% |
| Q2 2025 | 48 | 3.54M | $26.01M | +27.5% |
| Q1 2025 | 45 | 2.71M | $20.90M | +34.7% |
| Q4 2024 | 39 | 2.00M | $23.95M | +5.2% |
Over the 8 quarters shown, institutional share counts increased 317% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2025 (+34.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.75M | $27.49M | 2.17% | Hold | |
| 1.47M | $10.75M | 0.00% | Add | |
| 1.18M | $8.61M | 0.00% | Add | |
| 681.33K | $5.00M | 0.00% | Add | |
| 246.87K | $1.81M | 0.00% | Add | |
| 243.37K | $1.78M | 0.00% | Add | |
| 203.88K | $1.49M | 0.00% | Add | |
| 169.72K | $1.24M | 0.03% | Add | |
| 107.17K | $785.53K | 0.00% | Reduce | |
| 56.24K | $412.25K | 0.00% | Reduce | |
| 40.40K | $296.13K | 0.00% | Add | |
| 32.98K | $241.71K | 0.00% | Add | |
| 30.00K | $219.93K | 0.00% | Add | |
| 29.25K | $214.41K | 0.00% | Reduce | |
| 25.27K | $185.21K | 0.00% | Hold | |
| 18.61K | $136.36K | 0.00% | Add | |
| 15.69K | $115.01K | 0.00% | Reduce | |
| 12.49K | $91.58K | 0.00% | Add | |
| 11.85K | $86.85K | 0.00% | Reduce | |
| 7.73K | $56.57K | 0.00% | Reduce | |
| 3.95K | $28.94K | 0.00% | Add | |
| 3.85K | $28.20K | 0.00% | Add | |
| 2.39K | $17.53K | 0.00% | Reduce | |
| 1.65K | $12.08K | 0.00% | New | |
| 774 | $5.67K | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.75M | $24.71M | 1.99% | New | |
| 993.94K | $6.55M | 0.00% | Add | |
| 954.42K | $6.29M | 0.56% | New | |
| 876.93K | $5.78M | 0.00% | Reduce | |
| 532.95K | $3.51M | 0.00% | New | |
| 532.95K | $3.51M | 0.00% | Add | |
| 184.29K | $1.21M | 0.00% | Add | |
| 184.29K | $1.21M | 0.00% | Add | |
| 184.29K | $1.21M | 0.00% | New | |
| 169.54K | $1.12M | 0.00% | Add | |
| 166.75K | $1.10M | 0.03% | Reduce | |
| 151.07K | $995.57K | 0.00% | Add | |
| 123.95K | $816.85K | 0.00% | Add | |
| 86.23K | $568.29K | 0.00% | Add | |
| 62.75K | $413.52K | 0.00% | Add | |
| 41.69K | $274.74K | 0.00% | Add | |
| 24.59K | $171.39K | 0.00% | Add | |
| 25.80K | $170.02K | 0.00% | Add | |
| 25.27K | $166.52K | 0.00% | Hold | |
| 24.50K | $161.49K | 0.00% | New | |
| 18.76K | $123.65K | 0.00% | Reduce | |
| 18.49K | $121.84K | 0.00% | New | |
| 18.49K | $121.84K | 0.00% | New | |
| 17.94K | $118.22K | 0.00% | Add | |
| 16.86K | $111.13K | 0.00% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 984.20K | $6.86M | 0.00% | New | |
| 758.63K | $5.29M | 0.00% | Add | |
| 431.41K | $3.01M | 0.00% | Add | |
| 216.33K | $1.51M | 0.00% | Add | |
| 170.84K | $1.19M | 0.03% | Add | |
| 165.24K | $1.15M | 0.00% | Reduce | |
| 165.24K | $1.15M | 0.00% | Reduce | |
| 137.68K | $959.64K | 0.00% | New | |
| 133.84K | $932.87K | 0.00% | Add | |
| 73.12K | $509.66K | 0.00% | Add | |
| 69.81K | $486.60K | 0.00% | New | |
| 43.14K | $300.71K | 0.00% | Add | |
| 25.27K | $176.12K | 0.00% | Add | |
| 21.83K | $154.12K | 0.00% | Hold | |
| 21.10K | $147.07K | 0.00% | Hold | |
| 21.09K | $146.98K | 0.00% | Add | |
| 18.72K | $130.46K | 0.00% | Add | |
| 13.81K | $96.24K | 0.00% | New | |
| 13.12K | $91.41K | 0.00% | Reduce | |
| 10.61K | $73.97K | 0.00% | Hold | |
| 10.54K | $73.45K | 0.00% | Add | |
| 9.98K | $69.58K | 0.00% | New | |
| 8.64K | $60.23K | 0.00% | Reduce | |
| 5.76K | $40.17K | 0.00% | Add | |
| 5.62K | $39.15K | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.20M | $8.48M | 0.00% | Add | |
| 720.29K | $5.09M | 0.00% | Add | |
| 423.22K | $2.99M | 0.00% | Add | |
| 202.22K | $1.43M | 0.00% | Add | |
| 169.16K | $1.19M | 0.00% | Add | |
| 169.16K | $1.19M | 0.00% | Add | |
| 162.91K | $1.15M | 0.03% | Reduce | |
| 128.85K | $909.72K | 0.00% | Add | |
| 54.50K | $384.76K | 0.00% | Add | |
| 41.20K | $290.89K | 0.00% | Add | |
| 31.11K | $219.62K | 0.00% | Add | |
| 24.80K | $175.09K | 0.00% | Reduce | |
| 21.83K | $154.12K | 0.00% | Hold | |
| 21.10K | $148.97K | 0.00% | Hold | |
| 18.53K | $130.83K | 0.00% | Add | |
| 14.03K | $99.06K | 0.00% | Add | |
| 12.92K | $91.21K | 0.00% | Add | |
| 12.77K | $91.00K | 0.00% | Add | |
| 10.90K | $76.97K | 0.00% | New | |
| 10.61K | $74.93K | 0.00% | Reduce | |
| 10.30K | $72.75K | 0.00% | Add | |
| 10.00K | $70.60K | 0.00% | Reduce | |
| 9.76K | $68.90K | 0.00% | Add | |
| 9.58K | $67.66K | 0.00% | Reduce | |
| 5.48K | $38.70K | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.15M | $8.58M | 0.00% | Hold | |
| 659.40K | $4.92M | 0.00% | Reduce | |
| 374.62K | $2.80M | 0.00% | Reduce | |
| 182.75K | $1.36M | 0.00% | Add | |
| 167.87K | $1.25M | 0.03% | Reduce | |
| 123.39K | $920.46K | 0.00% | Reduce | |
| 123.39K | $920.46K | 0.00% | Reduce | |
| 116.34K | $867.91K | 0.00% | Reduce | |
| 39.00K | $290.94K | 0.00% | Add | |
| 35.75K | $266.70K | 0.00% | New | |
| 35.75K | $266.70K | 0.00% | New | |
| 24.40K | $182.01K | 0.00% | Add | |
| 22.96K | $171.30K | 0.00% | Add | |
| 21.83K | $162.85K | 0.00% | Add | |
| 21.10K | $157.41K | 0.00% | Add | |
| 18.03K | $134.53K | 0.00% | New | |
| 14.93K | $111.39K | 0.00% | New | |
| 14.93K | $111.39K | 0.00% | New | |
| 13.43K | $100.20K | 0.00% | Reduce | |
| 13.40K | $99.93K | 0.00% | Reduce | |
| 12.96K | $96.67K | 0.00% | New | |
| 12.39K | $92.00K | 0.00% | Add | |
| 10.93K | $81.52K | 0.00% | Hold | |
| 10.20K | $76.12K | 0.00% | Reduce | |
| 8.98K | $67.00K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.15M | $8.45M | 0.00% | Add | |
| 842.61K | $6.19M | 0.00% | Add | |
| 401.71K | $2.95M | 0.00% | Add | |
| 232.30K | $1.71M | 0.05% | Add | |
| 177.77K | $1.31M | 0.00% | Add | |
| 143.33K | $1.05M | 0.00% | Add | |
| 129.42K | $951.24K | 0.00% | Add | |
| 129.42K | $951.24K | 0.00% | Add | |
| 37.67K | $276.88K | 0.00% | New | |
| 35.91K | $263.95K | 0.00% | Add | |
| 35.26K | $259.15K | 0.00% | Add | |
| 24.00K | $176.43K | 0.00% | Add | |
| 23.99K | $176.32K | 0.00% | Add | |
| 19.93K | $146.49K | 0.00% | New | |
| 17.59K | $129.32K | 0.00% | New | |
| 16.19K | $118.96K | 0.00% | Add | |
| 13.35K | $98.09K | 0.00% | New | |
| 13.30K | $97.75K | 0.00% | New | |
| 11.29K | $82.99K | 0.00% | Reduce | |
| 10.93K | $80.31K | 0.00% | New | |
| 10.89K | $80.06K | 0.00% | Add | |
| 8.64K | $63.50K | 0.00% | Reduce | |
| 7.41K | $54.49K | 0.00% | Add | |
| 7.01K | $51.56K | 0.00% | Add | |
| 6.46K | $47.49K | 0.00% | Add |
New Positions (Q2 2026)
- HSG Holding Ltd 3.75M sh · $24.71M
- Octagon Capital Advisors LP 954.42K sh · $6.29M
- GEODE CAPITAL MANAGEMENT, LLC 532.95K sh · $3.51M
- Sixth Street Partners Management Company, L.P. 184.29K sh · $1.21M
- Nuveen, LLC 24.50K sh · $161.49K
- Millennium Management 18.49K sh · $121.84K
- MILLENNIUM MANAGEMENT LLC 18.49K sh · $121.84K
- PRICE T ROWE ASSOCIATES INC /MD/ 15.03K sh · $100.00K
- Polymer Capital Management (US) LLC 11.78K sh · $77.63K
- Arax Advisory Partners 246 sh · $1.62K
- Physician Wealth Advisors, Inc. 82 sh · $541
- Bare Financial Services, Inc 79 sh · $521
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 216.33K sh · $1.51M
- Brevan Howard Capital Management LP sold 13.81K sh · $96.24K
- SIMPLEX TRADING, LLC sold 674 sh · $4.70K
- CWM, LLC sold 104 sh · $725
- NISA INVESTMENT ADVISORS, LLC sold 102 sh · $711
- US BANCORP \DE\ sold 98 sh · $683
- Advisory Services Network, LLC sold 66 sh · $460
- MassMutual Private Wealth & Trust, FSB sold 12 sh · $84
- MAI Capital Management sold 4 sh · $28
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSG Holding Ltd | 3.75M | 3.75M | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.47M | 876.93K | 984.20K | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 1.18M | 993.94K | 758.63K | 720.29K | 659.40K | 842.61K | 547.21K | 531.68K | 514.42K | — | — | — |
| Geode Capital Management | 681.33K | 532.95K | 431.41K | 423.22K | 374.62K | 401.71K | 312.32K | 304.10K | 303.65K | 259.81K | 160.59K | 134.43K |
| STATE STREET CORP | 246.87K | — | 216.33K | 202.22K | 182.75K | 177.77K | 128.77K | 126.65K | 104.49K | 96.08K | 40.54K | 14.34K |
| VANGUARD FIDUCIARY TRUST CO | 243.37K | 151.07K | 137.68K | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 203.88K | 18.76K | 21.09K | 9.58K | 22.96K | 8.64K | 24.31K | 57.08K | 3.64K | 2.12K | — | 333 |
| SBI Securities Co., Ltd. | 169.72K | 166.75K | 170.84K | 162.91K | 167.87K | 232.30K | 123.63K | 101.24K | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 107.17K | 123.95K | 69.81K | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 56.24K | 62.75K | 43.14K | 41.20K | 24.40K | 23.99K | 16.49K | 13.90K | 12.51K | 18.27K | — | — |
| STRS OHIO | 40.40K | 25.80K | 21.10K | 21.10K | 21.10K | 13.30K | — | — | — | — | — | — |
| BARCLAYS PLC | 32.98K | 3.23K | 2.30K | 18.53K | 13.40K | 24.00K | 8.45K | 10.54K | 9.29K | 2.43K | — | — |
| Nuveen, LLC | 30.00K | 24.50K | — | — | — | 17.59K | — | — | — | — | — | — |
| Morgan Stanley | 29.25K | 41.69K | 8.64K | 54.50K | 8.98K | 35.26K | 14.03K | 15.24K | 18.22K | 7.27K | 5.71K | — |
| DIMENSIONAL FUND ADVISORS LP | 25.27K | 25.27K | 25.27K | 10.90K | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 18.61K | 16.86K | 13.12K | 14.03K | 13.43K | 16.19K | 11.14K | 10.43K | 10.42K | 10.29K | — | — |
| Deutsche Bank AG | 15.69K | 17.94K | 10.61K | 10.61K | 10.93K | 10.93K | — | — | — | — | — | — |
| Vanguard Global Advisers, LLC | 12.49K | 9.98K | 9.98K | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 11.85K | 14.97K | 18.72K | 10.30K | 10.20K | 10.89K | 376 | 1.26K | 3.74K | — | — | — |
| JPMorgan Chase & Co | 7.73K | 7.83K | 5.18K | 5.11K | 3.69K | 6.46K | 3.50K | 3.27K | 3.03K | 2.98K | 20.03K | 292 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold GYRE?
As of 2026-Q2, 63 institutional funds reported holding GYRE (GYRE THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $61.56M.
How many shares of GYRE do institutions own?
13F filers reported 9.35M shares of GYRE, worth $61.56M in aggregate at the end of 2026-Q2.
Is institutional ownership of GYRE rising or falling?
Share counts moved +14.6% versus the prior quarter — accumulation.
Who are the top institutional holders of GYRE?
The largest 13F holders are HSG Holding Ltd, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock Inc, Vanguard Group, Octagon Capital Advisors LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of GYRE THERAPEUTICS INC?
The major shareholders of GYRE THERAPEUTICS INC (GYRE) by reported 13F value are HSG Holding Ltd, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock Inc, Vanguard Group, Octagon Capital Advisors LP, among 106 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.